Home/Filings/4/0000899243-19-001114
4//SEC Filing

Balak Salesh 4

Accession 0000899243-19-001114

CIK 0001279695other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 1:54 PM ET

Size

19.2 KB

Accession

0000899243-19-001114

Insider Transaction Report

Form 4
Period: 2018-11-16
Balak Salesh
Chief Financial Officier
Transactions
  • Exercise/Conversion

    Common Stock

    2018-11-16+25,000124,058 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-11-1625,0000 total
    Exercise: $0.00Exp: 2018-11-17Common Stock (25,000 underlying)
  • Award

    Common Stock

    2018-12-14+4,166128,224 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $0.50Exp: 2023-04-20Common Stock (721,000 underlying)
    721,000
  • Stock Option (Right to Buy)

    Exercise: $0.00Exp: 2022-01-29Common Stock (40,000 underlying)
    40,000
  • Stock Option (Right to Buy)

    Exercise: $0.00Exp: 2020-12-11Common Stock (40,000 underlying)
    40,000
  • Stock Option (Right to Buy)

    Exercise: $0.00Exp: 2019-06-28Common Stock (73,334 underlying)
    73,334
  • Stock Option (Right to Buy)

    Exercise: $0.50Exp: 2024-02-27Common Stock (216,300 underlying)
    216,300
  • Stock Option (Right to Buy)

    Exercise: $0.00Exp: 2019-11-12Common Stock (25,000 underlying)
    25,000
  • Stock Option (Right to Buy)

    Exercise: $1.72Exp: 2019-11-09Common Stock (100,000 underlying)
    100,000
Footnotes (10)
  • [F1]The price reported is stated in Australian dollars.
  • [F10]Includes (i) 118,528 shares in the form of CDIs Mr. Balak holds directly and (ii) 9,696 restricted fully paid shares.
  • [F2]13,333 stock options vested and became exercisable on 12/31/2015, 13,333 stock options vested and became exercisable on 12/31/2016, and 13,334 stock options vested and became exercisable on 12/31/2017.
  • [F3]13,333 stock options vested and became exercisable on 12/31/2014, 13,333 stock options vested and became exercisable on 12/31/2015, and 13,334 stock options vested and became exercisable on 12/31/2016.
  • [F4]8,333 stock options vested and became exercisable on 12/31/2013, 8,333 stock options vested and became exercisable on 12/31/2014, and 8,334 stock options vested and became exercisable on 12/31/2015.
  • [F5]8,333 stock options vested and became exercisable on 12/31/2012, 8,333 stock options vested and became exercisable on 12/31/2013, and 8,334 stock options vested and became exercisable on 12/31/2014. These options were all exercised on 11/16/2018.
  • [F6]1/3 of the stock options vested and became exercisable on 12/31/2010, 1/3 of the stock options vested and became exercisable on 12/31/2011 and the remaining stock options vested and became exercisable on 12/31/2012.
  • [F7]10,000 stock options vested and became exercisable on 12/31/2010 and were exercised on 11/10/2011. 21,666 stock options vested and became exercisable on 12/31/11 and were exercised on 08/27/2012, 35,000 stock options vested and became exercisable on 12/31/2012, 25,000 stock options vested and became exercisable on 12/31/2013, and 13,334 stock options vested and became exercisable on 12/31/2014.
  • [F8]206,000 of the stock options vested and became exercisable on October 5, 2016, 412,000 of the stock options vested and became exercisable on December 31, 2016 and 103,000 of the stock options vested and became exercisable on February 23, 2017.
  • [F9]216,300 stock options vested and became exercisable on December 31, 2017.

Issuer

UNIVERSAL BIOSENSORS INC

CIK 0001279695

Entity typeother

Related Parties

1
  • filerCIK 0001397500

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 1:54 PM ET
Size
19.2 KB